Regeneron(REGN)2025-01-14 00:08Key Points Company and Industry Information 1. Company Presentation: The presentation is being made by Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) at the 43rd Annual J.P. Morgan Healthcare Conference 2025 on January 13, 2025 [3]. 2. Industry: The company operates in the biotechnology industry [2]. 3. Management Team: Leonard Schleifer is the Board Co-Chair, Co-Founder, President, and CEO, while George Yancopoulos is the Co-Founder, Board Co-Chair, President, and CSO [3]. Core Views and Arguments 1. Longevity in Industry: Leonard Schleifer highlights his long-standing experience in the biotechnology industry, emphasizing his role as the longest-serving CEO and part of the longest-serving management team in the industry [2]. 2. Investor Focus: Schleifer emphasizes that investors are always interested in knowing what unique aspects of the company make it a worthy investment [2]. Other Important Content 1. Introduction: The conference call is introduced by Chris Schott from J.P. Morgan, who expresses his pleasure in introducing Regeneron and looks forward to the presentation [3]. 2. Backward-Looking Statements: Leonard Schleifer mentions making backward-looking statements during the presentation, suggesting a focus on past achievements and experiences [4].